-
1
-
-
71149083715
-
Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients
-
Prévost A., Papathanassiou D., Jovenin N., et al. Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients. Rev Pneumol Clin 65 (2009) 341-349
-
(2009)
Rev Pneumol Clin
, vol.65
, pp. 341-349
-
-
Prévost, A.1
Papathanassiou, D.2
Jovenin, N.3
-
2
-
-
77949266477
-
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques
-
Aukema T.S., Rutgers E.J., Vogel W.V., et al. The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques. Eur J Surg Oncol 36 4 (2010) 387-392
-
(2010)
Eur J Surg Oncol
, vol.36
, Issue.4
, pp. 387-392
-
-
Aukema, T.S.1
Rutgers, E.J.2
Vogel, W.V.3
-
3
-
-
71049138078
-
18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation-where do we stand?
-
18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation-where do we stand?. Leuk Lymphoma 50 (2009) 1753-1756
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 1753-1756
-
-
Meignan, M.1
Itti, E.2
Gallamini, A.3
-
4
-
-
70349317256
-
18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial
-
18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 27 (2009) 4385-4391
-
(2009)
J Clin Oncol
, vol.27
, pp. 4385-4391
-
-
Furth, C.1
Steffen, I.G.2
Amthauer, H.3
-
5
-
-
70350274590
-
18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma
-
18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma. Ann Hematol 88 (2009) 1229-1236
-
(2009)
Ann Hematol
, vol.88
, pp. 1229-1236
-
-
Crocchiolo, R.1
Fallanca, F.2
Giovacchini, G.3
-
6
-
-
64649086758
-
18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma
-
18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27 (2009) 1781-1787
-
(2009)
J Clin Oncol
, vol.27
, pp. 1781-1787
-
-
Zinzani, P.L.1
Stefoni, V.2
Tani, M.3
-
7
-
-
70349644005
-
18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies
-
18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50 (2009) 1638-1645
-
(2009)
J Nucl Med
, vol.50
, pp. 1638-1645
-
-
Lim, S.M.1
Katsifis, A.2
Villemagne, V.L.3
-
8
-
-
66249119999
-
Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment
-
Noble J.M., and Scarmeas N. Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment. Int Rev Neurobiol. 84 (2009) 133-149
-
(2009)
Int Rev Neurobiol.
, vol.84
, pp. 133-149
-
-
Noble, J.M.1
Scarmeas, N.2
-
10
-
-
0032736192
-
18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer
-
18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer. BJU Int 84 (1999) 1028-1031
-
(1999)
BJU Int
, vol.84
, pp. 1028-1031
-
-
Sanz, G.1
Robles, J.E.2
Giménez, M.3
-
13
-
-
70549087099
-
Molecular imaging (PET) of brain tumors
-
Basu S., and Alavi A. Molecular imaging (PET) of brain tumors. Neuroimaging Clin N Am. 19 (2009) 625-646
-
(2009)
Neuroimaging Clin N Am.
, vol.19
, pp. 625-646
-
-
Basu, S.1
Alavi, A.2
-
14
-
-
77649122104
-
Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings
-
Perko R., Messinger Y., and Moertel C. Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings. Pediatr Blood Cancer 54 4 (2010) 621-623
-
(2010)
Pediatr Blood Cancer
, vol.54
, Issue.4
, pp. 621-623
-
-
Perko, R.1
Messinger, Y.2
Moertel, C.3
-
15
-
-
72149131242
-
False positive diagnosis of malignancy in a case of cryptogenic organising pneumonia presenting as a pulmonary mass with mediastinal nodes detected on fluorodeoxyglucose-positron emission tomography: a case report
-
Ponnuswamy A., Mediratta N., Lyburn I.D., et al. False positive diagnosis of malignancy in a case of cryptogenic organising pneumonia presenting as a pulmonary mass with mediastinal nodes detected on fluorodeoxyglucose-positron emission tomography: a case report. J Med Case Reports 3 (2009) 124
-
(2009)
J Med Case Reports
, vol.3
, pp. 124
-
-
Ponnuswamy, A.1
Mediratta, N.2
Lyburn, I.D.3
-
17
-
-
67650079957
-
The clinical value of myocardial blood flow measurement
-
Epub 2009 Jun 12
-
Camici P.G., and Rimoldi O.E. The clinical value of myocardial blood flow measurement. J Nucl Med 50 (2009) 1076-1087 Epub 2009 Jun 12
-
(2009)
J Nucl Med
, vol.50
, pp. 1076-1087
-
-
Camici, P.G.1
Rimoldi, O.E.2
-
19
-
-
0037374728
-
18F]fluorodeoxyglucose-positron emission tomography
-
18F]fluorodeoxyglucose-positron emission tomography. J Urol 169 (2003) 1337-1340
-
(2003)
J Urol
, vol.169
, pp. 1337-1340
-
-
Picchio, M.1
Messa, C.2
Landoni, C.3
-
20
-
-
0036673638
-
18F]FDG with positron emission tomography in recurrence of prostate cancer
-
18F]FDG with positron emission tomography in recurrence of prostate cancer. AJR Am J Roentgenol 179 (2002) 482-484
-
(2002)
AJR Am J Roentgenol
, vol.179
, pp. 482-484
-
-
Picchio, M.1
Landoni, C.2
Messa, C.3
-
21
-
-
0038311920
-
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer
-
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 44 (2003) 32-38
-
(2003)
Eur Urol
, vol.44
, pp. 32-38
-
-
de Jong, I.J.1
Pruim, J.2
Elsinga, P.H.3
-
22
-
-
69449087191
-
11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
-
11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 50 (2009) 1394-1400
-
(2009)
J Nucl Med
, vol.50
, pp. 1394-1400
-
-
Castellucci, P.1
Fuccio, C.2
Nanni, C.3
-
23
-
-
33644673784
-
11)C-choline PET/CT with histopathologic step-section analysis
-
11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46 (2005) 1642-1649
-
(2005)
J Nucl Med
, vol.46
, pp. 1642-1649
-
-
Farsad, M.1
Schiavina, R.2
Castellucci, P.3
-
24
-
-
34547167515
-
18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
-
18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. World J Surg Oncol 5 (2007) 68
-
(2007)
World J Surg Oncol
, vol.5
, pp. 68
-
-
Nanni, C.1
Zamagni, E.2
Cavo, M.3
-
25
-
-
10344224054
-
18fluorine fluorocholine positron emission tomography
-
18fluorine fluorocholine positron emission tomography. J Urol 173 (2005) 252-255
-
(2005)
J Urol
, vol.173
, pp. 252-255
-
-
Kwee, S.A.1
Coel, M.N.2
Lim, J.3
-
28
-
-
33645835922
-
Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml?
-
Heinisch M., Dirisamer A., Loidl W., et al. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml?. Mol Imaging Biol. 8 (2006) 43
-
(2006)
Mol Imaging Biol.
, vol.8
, pp. 43
-
-
Heinisch, M.1
Dirisamer, A.2
Loidl, W.3
-
29
-
-
33845357517
-
18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients
-
Epub 2006 Jul 25
-
18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 33 (2006) 1387-1398 Epub 2006 Jul 25
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 1387-1398
-
-
Cimitan, M.1
Bortolus, R.2
Morassut, S.3
-
30
-
-
36849040584
-
PET/CT imaging of recurrent prostate cancer
-
Scher B., and Seitz M. PET/CT imaging of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 35 (2008) 5-8
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 5-8
-
-
Scher, B.1
Seitz, M.2
-
31
-
-
17644416782
-
Fluorocholine PET/CT in patients with prostate cancer: initial experience
-
Schmid D.T., John H., Zweifel R., et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 235 (2005) 623-628
-
(2005)
Radiology
, vol.235
, pp. 623-628
-
-
Schmid, D.T.1
John, H.2
Zweifel, R.3
-
34
-
-
33644525935
-
Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures
-
Pirotte B., Goldman S., Dewitte O., et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 104 (2006) 238-253
-
(2006)
J Neurosurg
, vol.104
, pp. 238-253
-
-
Pirotte, B.1
Goldman, S.2
Dewitte, O.3
-
35
-
-
37049003735
-
The role of advanced MR in understanding brain tumors pathology
-
Price S.J. The role of advanced MR in understanding brain tumors pathology. Br J Neurosurg 21 (2007) 562-575
-
(2007)
Br J Neurosurg
, vol.21
, pp. 562-575
-
-
Price, S.J.1
-
37
-
-
12444257678
-
11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
-
11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32 (2005) 39-51
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, pp. 39-51
-
-
Van Laere, K.1
Ceyssens, S.2
Van Calenbergh, F.3
-
38
-
-
0031596996
-
11C-methionine PET for differential diagnosis of low-grade gliomas
-
11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 (1998) 1316-1322
-
(1998)
Neurology
, vol.50
, pp. 1316-1322
-
-
Herholz, K.1
Hölzer, T.2
Bauer, B.3
-
39
-
-
0034756420
-
Positron emission tomography with injection of methionine as a prognostic factor in glioma
-
De Witte O., Goldberg I., Wikler D., et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95 (2001) 746-750
-
(2001)
J Neurosurg
, vol.95
, pp. 746-750
-
-
De Witte, O.1
Goldberg, I.2
Wikler, D.3
-
40
-
-
0035883412
-
Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas
-
Ribom D., Eriksson A., Hartman M., et al. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92 (2001) 1541-1549
-
(2001)
Cancer
, vol.92
, pp. 1541-1549
-
-
Ribom, D.1
Eriksson, A.2
Hartman, M.3
-
43
-
-
33750451966
-
Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results
-
Sadeghi N., Salmon I., Tang B.N., et al. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. J Magn Reson Imaging 24 (2006) 989-994
-
(2006)
J Magn Reson Imaging
, vol.24
, pp. 989-994
-
-
Sadeghi, N.1
Salmon, I.2
Tang, B.N.3
-
44
-
-
4544337743
-
11C-methionine for PET-guided stereotactic brain biopsy of gliomas
-
11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45 (2004) 1293-1298
-
(2004)
J Nucl Med
, vol.45
, pp. 1293-1298
-
-
Pirotte, B.1
Goldman, S.2
Massager, N.3
-
45
-
-
2542431960
-
11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT
-
11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 71 (2004) 267-273
-
(2004)
Radiother Oncol
, vol.71
, pp. 267-273
-
-
Geetsa, X.1
Daisnea, J.-F.2
Gregoirea, V.3
-
46
-
-
33645858290
-
11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis
-
11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging 33 (2006) 453-459
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 453-459
-
-
Rubello, D.1
Fanti, S.2
Nanni, C.3
-
49
-
-
13944280319
-
11C-methionine positron emission tomography
-
11C-methionine positron emission tomography. Nucl Med Commun 26 (2005) 133-136
-
(2005)
Nucl Med Commun
, vol.26
, pp. 133-136
-
-
Beggs, A.D.1
Hain, S.F.2
-
51
-
-
68449102377
-
11C]-methionine PET for detection and localization of suspected parathyroid adenomas
-
11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Mol Imaging Biol. 11 (2009) 356-363
-
(2009)
Mol Imaging Biol.
, vol.11
, pp. 356-363
-
-
Herrmann, K.1
Takei, T.2
Kanegae, K.3
-
52
-
-
0028962933
-
Pancreatic neuroendocrine tumors: diagnosis with PET
-
Ahlstrom H., Eriksson B., Bergstrom M., et al. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 195 (1995) 333-337
-
(1995)
Radiology
, vol.195
, pp. 333-337
-
-
Ahlstrom, H.1
Eriksson, B.2
Bergstrom, M.3
-
56
-
-
19944362186
-
Imaging of pheochromocytoma and paraganglioma
-
Brink I., Hoegerle S., Klisch J., et al. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 4 (2005) 61-68
-
(2005)
Fam Cancer
, vol.4
, pp. 61-68
-
-
Brink, I.1
Hoegerle, S.2
Klisch, J.3
-
57
-
-
0034746433
-
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
-
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 28 (2001) 64-71
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 64-71
-
-
Hoegerle, S.1
Altehoefer, C.2
Ghanem, N.3
-
59
-
-
31444451405
-
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease
-
Eshuis S.A., Maguire R.P., Leenders K.L., et al. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur J Nucl Med Mol Imaging 33 (2006) 200-209
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 200-209
-
-
Eshuis, S.A.1
Maguire, R.P.2
Leenders, K.L.3
-
60
-
-
0025695511
-
The nigro-striatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's Disease
-
Leenders K.L., Salmon E.P., Tyrrell P., et al. The nigro-striatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's Disease. Arch Neurol 47 (1990) 1290-1298
-
(1990)
Arch Neurol
, vol.47
, pp. 1290-1298
-
-
Leenders, K.L.1
Salmon, E.P.2
Tyrrell, P.3
-
61
-
-
0022551086
-
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography
-
Leenders K.L., Palmer A.J., Quinn N., et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 49 (1986) 853-860
-
(1986)
J Neurol Neurosurg Psychiatry
, vol.49
, pp. 853-860
-
-
Leenders, K.L.1
Palmer, A.J.2
Quinn, N.3
-
62
-
-
17344383647
-
18-FPCT: a PET radiotracer for imaging dopamine transporters
-
18-FPCT: a PET radiotracer for imaging dopamine transporters. J Nucl Med 38 (1997) 119-126
-
(1997)
J Nucl Med
, vol.38
, pp. 119-126
-
-
Goodman, M.M.1
Keil, R.2
Shoup, T.M.3
-
63
-
-
0025373167
-
Compensations after lesions of central dopaminergic neurons: some clinical and basic implications
-
Zigmond M.J., Abercrombie E.D., Berger T.W., et al. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13 (1990) 290-296
-
(1990)
Trends Neurosci
, vol.13
, pp. 290-296
-
-
Zigmond, M.J.1
Abercrombie, E.D.2
Berger, T.W.3
-
64
-
-
14844340284
-
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs
-
Kwekkeboom D.J., Mueller-Brand J., Paganelli G., et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 46 (2005) 62S-66S
-
(2005)
J Nucl Med
, vol.46
-
-
Kwekkeboom, D.J.1
Mueller-Brand, J.2
Paganelli, G.3
-
65
-
-
21244490346
-
68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5
-
Wild D., Mäcke H.R., Waser B., et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging 32 (2005) 724
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, pp. 724
-
-
Wild, D.1
Mäcke, H.R.2
Waser, B.3
-
66
-
-
0141996533
-
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
-
Wild D., Schmitt J.S., Ginj M., et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur J Nucl Med Mol Imaging 30 (2003) 1338-1347
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 1338-1347
-
-
Wild, D.1
Schmitt, J.S.2
Ginj, M.3
-
67
-
-
12944329895
-
Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy
-
Ginj M., Chen J., Walter M.A., et al. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clin Cancer Res 11 (2005) 1136-1145
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1136-1145
-
-
Ginj, M.1
Chen, J.2
Walter, M.A.3
-
68
-
-
48149085905
-
18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
-
Epub 2008 Apr 17
-
18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging 35 (2008) 1431-1438 Epub 2008 Apr 17
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 1431-1438
-
-
Ambrosini, V.1
Tomassetti, P.2
Castellucci, P.3
-
69
-
-
34250349188
-
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
-
Antunes P., Ginj M., and Zhang H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?. Eur J Nucl Med Mol Imaging 34 (2007) 982-993
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 982-993
-
-
Antunes, P.1
Ginj, M.2
Zhang, H.3
-
71
-
-
85060774767
-
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma
-
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 44 (2003) 2
-
(2003)
J Nucl Med
, vol.44
, pp. 2
-
-
Delbeke, D.1
Wright Pinson, C.2
-
72
-
-
57149101558
-
11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma
-
11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49 (2008) 1912-1921
-
(2008)
J Nucl Med
, vol.49
, pp. 1912-1921
-
-
Park, J.W.1
Kim, J.H.2
Kim, S.K.3
-
75
-
-
46749137956
-
Imaging of cell proliferation: status and prospects
-
Bading J.R., and Shields A.F. Imaging of cell proliferation: status and prospects. J Nucl Med 49 (2008) 64S-80S
-
(2008)
J Nucl Med
, vol.49
-
-
Bading, J.R.1
Shields, A.F.2
-
76
-
-
34848871896
-
18F-labeled positron emission tomographic radiopharmaceuticals in oncology: An overview of radiochemistry and mechanisms of tumor localization
-
18F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med; 37:400-419.
-
Semin Nucl Med
, vol.37
, pp. 400-419
-
-
Vallabhajosula, S.1
-
77
-
-
33746920876
-
Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology
-
Shields A.F. Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology. Mol Imaging Biol 8 (2006) 141-150
-
(2006)
Mol Imaging Biol
, vol.8
, pp. 141-150
-
-
Shields, A.F.1
-
78
-
-
27144473355
-
True tracers: comparing FDG with glucose and FLT with thymidine
-
Krohn K.A., Mankoff D.A., Muzi M., et al. True tracers: comparing FDG with glucose and FLT with thymidine. Nucl Med Biol 32 (2005) 663-671
-
(2005)
Nucl Med Biol
, vol.32
, pp. 663-671
-
-
Krohn, K.A.1
Mankoff, D.A.2
Muzi, M.3
-
79
-
-
0034743498
-
Imaging cellular proliferation as a measure of response to therapy
-
Krohn K.A., Mankoff D.A., and Eary J.F. Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol 41 (2001) 96S-103S
-
(2001)
J Clin Pharmacol
, vol.41
-
-
Krohn, K.A.1
Mankoff, D.A.2
Eary, J.F.3
-
80
-
-
68949210520
-
New PET tracers for evaluation of solid tumors response to therapy
-
Larson S.M., and Schoder H. New PET tracers for evaluation of solid tumors response to therapy. Q J Nucl Med Mol Imaging 53 (2009) 158-166
-
(2009)
Q J Nucl Med Mol Imaging
, vol.53
, pp. 158-166
-
-
Larson, S.M.1
Schoder, H.2
-
81
-
-
34548078982
-
18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
-
18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging 34 (2007) 1316-1317
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1316-1317
-
-
Beheshti, M.1
Vali, R.2
Langsteger, W.3
-
82
-
-
0034938846
-
PET imaging of hypoxia
-
Lewis J.S., and Welch M.J. PET imaging of hypoxia. Q J Nucl Med 45 (2001) 183-188
-
(2001)
Q J Nucl Med
, vol.45
, pp. 183-188
-
-
Lewis, J.S.1
Welch, M.J.2
-
83
-
-
0029815801
-
Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia
-
Yoshida K., Mullani N., and Gould K.L. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 37 (1996) 1701-1712
-
(1996)
J Nucl Med
, vol.37
, pp. 1701-1712
-
-
Yoshida, K.1
Mullani, N.2
Gould, K.L.3
-
84
-
-
0027986854
-
Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM
-
Beanlands R.S., Muzik O., Hutchins G.D., et al. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM. J Nucl Cardiol 1 (1994) 225-235
-
(1994)
J Nucl Cardiol
, vol.1
, pp. 225-235
-
-
Beanlands, R.S.1
Muzik, O.2
Hutchins, G.D.3
-
85
-
-
11844283377
-
Cardiovascular molecular imaging
-
Dobrucki L.W., and Sinusas A.J. Cardiovascular molecular imaging. Semin Nucl Med 35 (2005) 73-81
-
(2005)
Semin Nucl Med
, vol.35
, pp. 73-81
-
-
Dobrucki, L.W.1
Sinusas, A.J.2
-
87
-
-
33846885522
-
PET of vascular endothelial growth factor receptor expression
-
Cai W., Chen K., Mohamedali K.A., et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med 47 (2006) 2048-2056
-
(2006)
J Nucl Med
, vol.47
, pp. 2048-2056
-
-
Cai, W.1
Chen, K.2
Mohamedali, K.A.3
-
88
-
-
33750420717
-
Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging
-
Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm 3 (2006) 472-487
-
(2006)
Mol Pharm
, vol.3
, pp. 472-487
-
-
Liu, S.1
-
89
-
-
33846408353
-
PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V
-
Cauchon N., Langlois R., Rousseau J.A., et al. PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging 34 (2007) 247-258
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 247-258
-
-
Cauchon, N.1
Langlois, R.2
Rousseau, J.A.3
-
90
-
-
33745080072
-
18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression
-
18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression. J Nucl Med 47 (2006) 706-715
-
(2006)
J Nucl Med
, vol.47
, pp. 706-715
-
-
Yaghoubi, S.S.1
Couto, M.A.2
Chen, C.C.3
-
92
-
-
0032996415
-
18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy
-
18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 26 (1999) 144-151
-
(1999)
Eur J Nucl Med
, vol.26
, pp. 144-151
-
-
Bader, J.B.1
Samnick, S.2
Moringlane, J.R.3
-
93
-
-
0033625413
-
11C]methionine uptake in brain tumours: initial results of a comparative study
-
11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27 (2000) 542-549
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 542-549
-
-
Weber, W.A.1
Wester, H.J.2
Grosu, A.L.3
-
94
-
-
34248551104
-
18F-fluoroethyl)- l-tyrosine PET and MRI in low-grade glioma
-
18F-fluoroethyl)- l-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48 (2007) 519-527
-
(2007)
J Nucl Med
, vol.48
, pp. 519-527
-
-
Floeth, F.W.1
Pauleit, D.2
Sabel, M.3
-
95
-
-
42349116826
-
18F]fluoroethyl)- l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment
-
18F]fluoroethyl)- l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment. J Neurooncol 88 (2008) 27-35
-
(2008)
J Neurooncol
, vol.88
, pp. 27-35
-
-
Mehrkens, J.H.1
Popperl, G.2
Rachinger, W.3
-
96
-
-
44149114514
-
18F-fluoroethyl- l-tyrosine PET and MRI in small nonspecific incidental brain lesions
-
18F-fluoroethyl- l-tyrosine PET and MRI in small nonspecific incidental brain lesions. J Nucl Med 49 (2008) 730-737
-
(2008)
J Nucl Med
, vol.49
, pp. 730-737
-
-
Floeth, F.W.1
Sabel, M.2
Stoffels, G.3
|